Last Price
16.60
Today's Change
-1.03 (5.84%)
Day's Change
16.14 - 17.74
Trading Volume
158,211
Overview
Market Cap
348 Million
Shares Outstanding
20 Million
Avg Volume
401,034
Avg Price (50 Days)
28.68
Avg Price (200 Days)
36.22
PE Ratio
-4.06
EPS
-4.09
Earnings Announcement
17-Feb-2025
Previous Close
17.63
Open
17.60
Day's Range
16.14 - 17.746
Year Range
14.44 - 74.49
Trading Volume
158,211
Price Change Highlight
1 Day Change
-5.84%
5 Day Change
-20.38%
1 Month Change
-30.02%
3 Month Change
-68.63%
6 Month Change
-62.56%
Ytd Change
-27.48%
1 Year Change
-44.96%
3 Year Change
-76.01%
5 Year Change
-92.14%
10 Year Change
-91.93%
Max Change
-93.05%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
Will Coinbase refund My Money, iF Scammed?
2
Will Coinbase refund My Money, iF Scammed?
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
